Explore a diverse range of content on OTT this week, from the hilarious banter of Koffee with Karan featuring Varun Dhawan and Sidharth Malhotra to the emotional..

Vivek Agnihotri helmed 'The Vaccine War' has been invited by the Academy for their library. The Academy of Motion Picture Arts and Sciences reached out to the..

Vivek Agnihotri, director of 'The Vaccine War,' has announced a 'buy 1 get 1' ticket offer for the movie. The film has been doing well at the box office and..

Directed by Vivek Agnihotri, The Vaccine War is based on the book ‘Going Viral’ by Prof Balram Bhargava, Director General – Indian Council of Medical..

'The Vaccine War' is touted to be India’s first ‘bio-science’ film as it tries to present the story of the scientists who developed India’s Covid-19..

Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four..

Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had..

Amid rising cases of H3N2 influenza virus in the country and reports of some deaths too, Hyderabad-based vaccine maker Bharat Biotech, which developed the..

Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for..

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a..

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken..

Ocugen Inc said on Monday the Covid-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United..

Govt-run centres only have Covaxin; state writes to Centre seeking Covishield, Corbevax

Bharat Biotech on Tuesday said that its intranasal Covid-19 vaccine iNCOVACC will be priced at Rs 800 per dose for the private markets and Rs 325 per dose for..

Noida residents experienced shortage of Covaxin and Covishield on Saturday, check out where you can get Covid-19 vaccine and booster dose.

The nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin.

With interest waning, BMC has also run out of Covishield and Corbevax stock, with just a few thousand doses of Covaxin left

The Central Drugs Standard Control Organization's Subject Expert Committee met on January 1 and 2, 2021 and made recommendations on Bharat Biotech's proposal for..

Those adults who got vaccinated with either Covaxin or Covishield will now be allowed to take the Corbevax dose, six months or 26 weeks after administration of..

India said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main..

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in India.

In what is the first heterologous booster shot to be approved, Biological E’s Covid-19 vaccine Corbevax is learnt to have received the government’s nod for..

 This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

government panel on Covid immunisation has recommended allowing Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield..

Health experts say the study has put the indigenous vaccine among global ones, but add that it needs long-term studies

Health experts say the study has put the indigenous vaccine among global ones, but say need long-term studies

Prime Minister Narendra Modi emphasised that all eligible children get the Covid-19 vaccine as soon as possible via "special programmes" in schools.

NTAGI is considering using Corbevax as a booster vaccination against Covid-19.

The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above. India's first indigenously-developed..

It conducted phase II/III, open-label, and multicentre study to evaluate the safety, reactogenicity and immunogenicity of Covaxin in children and adolescents in..

The researchers compared the efficacy of Covaxin after the second and third doses against the Delta variant, and also studied its efficacy against the Omicron..

The findings of the study by ICMR have been published on Tuesday on bioRxiv, a pre-print server and have not been peer-reviewed.

Allowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin and reducing the gap between the..

Covaxin was issued emergency use listing (EUL) by the World Health Organization (WHO) last November.

“Germany has approved Covaxin COVID19 vaccine. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions,” Bharat..

The US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech's Covid-19 vaccine Covaxin, in USA, has lifted the..

The US Food and Drug Administration (USFDA) has lifted the clinical hold on the Phase 2 and 3 immuno-bridging clinical trials of Bharat Biotech’s Covid-19..

There were 416 patients aged 18 to 80 who got two doses of Covaxin or Covishield, the last one six months before the Corbevax booster.

Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population.

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two..

Weeks after WHO suspended the supply of Covaxin through UN procurement agencies, the MEA suggested that vaccine-maker Bharat Biotech addresses the issue..

Thousands of NRIs, who are back in India after taking Covid vaccines other than Covishield or Covaxin, now face a unique problem: they are unable to get the..